Cambridge, United States
Research view
Switch to patient viewMigraine: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- CGRP 19
- HMGB1 0
- NOTCH3 0
- GLP-1 0
- MAPK 0
- PI3K 0
- IL-17 0
- IL-6 1
- TNF 1
- PPAR 0
- TREM2 0
- COX-2 0
- IL-4 0
- STING 0
- AKT 0
- AMPK 0
- AQP4 0
- ERK 0
- GIP 0
- GPX4 0
- HIF-1 0
- IL-1 1
- mTOR 0
- NLRP3 0
- NMDA 0
- PD-1 0
- SCN1A 0
- SCN2A 0
- STAT3 0
- VEGF 0
Copenhagen, Denmark
London, United Kingdom
Rochester, United States
Bronx, United States
Rome, Italy
Beijing, China
Copenhagen, Denmark
Pavia, Italy
Copenhagen, Denmark
L’Aquila, Italy
Berlin, Germany
Barcelona, Spain
Paris, France
Trondheim, Norway
Cairo University · Giza, Egypt
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Curr Pain Headache Rep, Feb 2026Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
São Paulo, Brazil
Istanbul, Türkiye
Philadelphia, United States
Cerdanyola del Vallès, Spain
Rome, Italy
Leiden, Netherlands
Barcelona, Spain
North Chicago, United States
24 of 1,517 institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-JU-IA
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-JU-RIA
Hospital@Home: Person-centered Digital Transformation for Integrated Home Care (HospitalAtHome)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF
European Commission (Horizon Europe) · HORIZON-EIC-ACC
INNOVATIVE SOLUTION OF ELECTRO-FOCUS EYEGLASSES (I-SEE)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
The disease is named only in the funder's project summary, not in the title.
5 of 6 running projects, newest first. Listed amounts together: €26.6m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
A Study of K-645 in the Treatment of Multiple Migraine Attacks
“Study stopped for futility based on an interim analysis of efficacy.”Registry text, quoted unchanged. Source
Withdrawn
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
“The study was not initiated. IRB review determined the study would require an investigational device exemption (IDE), and the sponsor elected not to proceed because resources were not available. No subjects were enrolled.”Registry text, quoted unchanged. Source
Suspended
Management of Acute Tinnitus With Migraine Medications
“Enrollment temporarily paused pending IRB continuing review; recruitment expected to resume.”Registry text, quoted unchanged. Source
Terminated
Migraine and CVD Risk in Women
“Investigator transition”Registry text, quoted unchanged. Source
Withdrawn
Oral Medications for the Management of Acute Migraine Headache in the Emergency Department
“The project proved not feasible to launch at Health Sciences North.”Registry text, quoted unchanged. Source
Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
“Administrative”Registry text, quoted unchanged. Source
Terminated
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
“Funding ended.”Registry text, quoted unchanged. Source
Terminated
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
“Dissatisfactory enrollment rate with no safety concerns”Registry text, quoted unchanged. Source
Terminated
Acute Migraine Treatment in the ED With Gepants
“Study closing at current site. Study to start as new at different site.”Registry text, quoted unchanged. Source
Suspended
Vibratory Stimulation for the Treatment of Chronic Pain
“New investigational devices are currently under development.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 7
- Mendelian Randomization Analysis 33
- Gene Expression Profiling 8
- Sequence Analysis, RNA 2
- Exome Sequencing 5
- Proteomics 6
- Metabolomics 6
- Mass Spectrometry 1
- Xenograft Model Antitumor Assays 2
- Positron-Emission Tomography 3
- Magnetic Resonance Imaging 136
- Machine Learning 32
- Deep Learning 1
- Cohort Studies 82
- Genome-Wide Association Study 40
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.